Inclusion Criteria:
  1. Age â‰¥ 18 years old;
  2. Diagnosed as a malignant solid tumor by histology and cytology, requiring chemotherapy patients;
  3. The first use of PEG-rhG-CSF during the chemotherapy cycle (not limited to the first chemotherapy cycle, can be any chemotherapy cycle of the patient);
  4. Subjects volunteered to participate in this clinical trial and signed informed consent.
Exclusion Criteria:
  1. PEG-rhG-CSF was used in the current chemotherapy cycle;
  2. Have received hematopoietic stem cell transplantation or bone marrow transplantation;
  3. Other drug clinical trials are currently underway.